Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: A comparison

European Respiratory Journal

Volumn 30, Issue 4, 2007, Pages 653-661

  Bos, I S T ^a   Gosens, R ^a,b   Zuidhof, A B ^a   Schaafsma, D ^a   Halayko, A J ^b   Meurs, H ^a   Zaagsma, J ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Airway remodelling; Airway smooth muscle; Anticholinergics; Asthma; Glucocorticosteroids; Mucus hypersecretion

Indexed keywords

ALLERGEN; BUDESONIDE; MYOSIN; OVALBUMIN; TIOTROPIUM BROMIDE; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; GLUCOCORTICOID; SCOPOLAMINE DERIVATIVE; TIOTROPIUM; UNCLASSIFIED DRUG;

AIRWAY; ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; DRUG MECHANISM; EOSINOPHILIA; GOBLET CELL; GUINEA PIG; HYPERTROPHY; MALE; MUSCLE CONTRACTILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; ANIMAL; CHEMISTRY; EXTRACELLULAR MATRIX; HUMAN; HYPERSENSITIVITY; INFLAMMATION; METABOLISM; PATHOLOGY; SMOOTH MUSCLE; TRACHEA;

ADRENAL CORTEX HORMONES; ALLERGENS; ANIMALS; BRONCHODILATOR AGENTS; BUDESONIDE; CHOLINERGIC ANTAGONISTS; EOSINOPHILIA; EXTRACELLULAR MATRIX; GLUCOCORTICOIDS; GUINEA PIGS; HUMANS; HYPERSENSITIVITY; INFLAMMATION; MALE; MUSCLE, SMOOTH; OVALBUMIN; SCOPOLAMINE DERIVATIVES; TRACHEA;

EID: 38449113726     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00004907     Document Type: Article

References (45)

1. Gosens R, Zaagsma J, Grootte Bromhaar M, Nelemans A, Meurs H. Acetylcholine: a novel regulator of airway smooth muscle remodelling? Eur J Pharmacol 2004; 500:193-201.
2. Gosens R, Zaagsma J, Meurs H, Halayko AJ. Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir Res 2006; 7: 73.
3. Racke K, Matthiesen S. The airway cholinergic system: physiology and pharmacology. Pulm Pharmacol Ther 2004; 17: 181-198.
4. Racke K, Juergens UR, Matthiesen S. Control by cholinergic mechanisms. Eur J Pharmacol 2006; 533: 57-68.
5. Belmonte KE. Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2: 297-304; discussion 311-312.
6. 2 receptors in bovine tracheal smooth muscle: discrepancies between binding and function. Eur J Pharmacol 1988; 153: 73-82.
7. 3 receptors mediate contraction of human central and peripheral airway smooth muscle. Pulm Pharmacol 1990; 3: 47-51.
8. Ramnarine SI, Haddad EB, Khawaja AM, Mak JC, Rogers DF. On muscarinic control of neurogenic mucus secretion in ferret trachea. J Physiol 1996; 494: 577-586.
9. Ishihara H, Shimura S, Satoh M, et al. Muscarinic receptor subtypes in feline tracheal submucosal gland secretion. Am J Physiol 1992; 262: L223-L228.
10. Gross NJ, Skorodin MS. Role of the parasympathetic system in airway obstruction due to emphysema. N Engl J Med 1984; 311: 421-425.
11. 3-receptors mediate cholinergic synergism of mitogenesis in airway smooth muscle. Am J Respir Cell Mol Biol 2003; 28: 257-262.
12. Liu HW, Kassiri K, Voros A, et al. Gaq-receptor coupled signaling induces RHO-dependent transcription of smooth muscle specific genes in cultured canine airway myocytes. Am J Respir Crit Care Med 2002; 165: A670.
13. Matthiesen S, Bahulayan A, Kempkens S, et al. Muscarinic receptors mediate stimulation of human lung fibroblast proliferation. Am J Respir Cell Mol Biol 2006; 35: 621-627.
14. Kanefsky J, Lenburg M, Hai CM. Cholinergic receptor and cyclic stretch-mediated inflammatory gene expression in intact ASM. Am J Respir Cell Mol Biol 2006; 34: 417-425.
15. Koyama S, Rennard SI, Robbins RA. Acetylcholine stimulates bronchial epithelial cells to release neutrophil and monocyte chemotactic activity. Am J Physiol 1992; 262: L466-L471.
16. Koyama S, Sato E, Nomura H, Kubo K, Nagai S, Izumi T. Acetylcholine and substance P stimulate bronchial epithelial cells to release eosinophil chemotactic activity. J Appl Physiol 1998; 84: 1528-1534.
17. Sato E, Koyama S, Okubo Y, Kubo K, Sekiguchi M. Acetylcholine stimulates alveolar macrophages to release inflammatory cell chemotactic activity. Am J Physiol 1998; 274: L970-L979.
18. 4 production and neutrophilic inflammation in COPD patients. Allergy 2005; 60: 1361-1369.
19. Gosens R, Bos IS, Zaagsma J, Meurs H. Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling. Am J Respir Crit Care Med 2005; 171: 1096-1102.
20. Meurs H, Santing RE, Remie R, et al. A guinea pig model of acute and chronic asthma using permanently instrumented and unrestrained animals. Nat Protoc 2006; 1: 840-847.
21. 2 agonist exposure on airway remodeling in guinea pigs. Am J Respir Crit Care Med 1995; 152: 2097-2104.
22. Chorley BN, Crews AL, Li Y, Adler KB, Minnicozzi M, Martin LD. Differential Muc2 and Muc5ac secretion by stimulated guinea pig tracheal epithelial cells in vitro. Respir Res 2006; 7: 35.
23. National Institutes of Health, ImageJ. Image Processing and Analysis in Java. http://rsb.info.nih.gov/ij/index.html Date last updated: July 23, 2007. Date last accessed: August 7, 2007.
24. Halayko AJ, Stelmack GL, Yamasaki A, McNeill K, Unruh H, Rector E. Distribution of phenotypically disparate myocyte subpopulations in airway smooth muscle. Can J Physiol Pharmacol 2005; 83: 104-116.
25. Jeffery PK. Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 2001; 164: S28-S38.
26. Postma DS, Timens W. Remodeling in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006; 3: 434-439.
27. Rogers DF. Mucus hypersecretion in chronic obstructive pulmonary disease. Novartis Found Symp 2001; 234: 65-83.
28. Rogers DF. Airway mucus hypersecretion in asthma: an undervalued pathology? Curr Opin Pharmacol 2004; 4: 241-250.
29. Guzman K, Bader T, Nettesheim P. Regulation of MUC5 and MUC1 gene expression: correlation with airway mucous differentiation. Am J Physiol 1996; 270: L846-L853.
30. Lou YP, Takeyama K, Grattan KM, et al. Platelet-activating factor induces goblet cell hyperplasia and mucin gene expression in airways. Am J Respir Crit Care Med 1998; 157: 1927-1934.
31. Vanacker NJ, Palmans E, Kips JC, Pauwels RA. Fluticasone inhibits but does not reverse allergen-induced structural airway changes. Am J Respir Crit Care Med 2001; 163: 674-679.
32. Ward C, Walters H. Airway wall remodelling: the influence of corticosteroids. Curr Opin Allergy Clin Immunol 2005; 5: 43-48.
33. Kanno H, Horikawa Y, Hodges RR, et al. Cholinergic agonists transactivate EGFR and stimulate MAPK to induce goblet cell secretion. Am J Physiol Cell Physiol 2003; 284: C988-C998.
34. Rogers DF. Motor control of airway goblet cells and glands. Respir Physiol 2001; 125: 129-144.
35. Wessler IK, Kirkpatrick CJ. The non-neuronal cholinergic system: an emerging drug target in the airways. Pulm Pharmacol Ther 2001; 14: 423-434.
36. Proskocil BJ, Sekhon HS, Jia Y, et al. Acetylcholine is an autocrine or paracrine hormone synthesized and secreted by airway bronchial epithelial cells. Endocrinology 2004; 145: 2498-2506.
37. Lips KS, Volk C, Schmitt BM, et al. Polyspecific cation transporters mediate luminal release of acetylcholine from bronchial epithelium. Am J Respir Cell Mol Biol 2005; 33: 79-88.
38. Kummer W, Wiegand S, Akinci S, et al. Role of acetylcholine and polyspecific cation transporters in serotonin-induced bronchoconstriction in the mouse. Respir Res 2006; 7: 65.
39. Halayko AJ, Tran T, Ji SY, Yamasaki A, Gosens R. Airway smooth muscle phenotype and function: interactions with current asthma therapies. Curr Drug Targets 2006; 7: 525-540.
40. Fernandes D, Guida E, Koutsoubos V, et al. Glucocorticoids inhibit proliferation, cyclin D1 expression, and retinoblastoma protein phosphorylation, but not activity of the extracellular-regulated kinases in human cultured airway smooth muscle. Am J Respir Cell Mol Biol 1999; 21: 77-88.
41. Roth M, Johnson PR, Borger P, et al. Dysfunctional interaction of C/EBPα and the glucocorticoid receptor in asthmatic bronchial smooth-muscle cells. N Engl J Med 2004; 351: 560-574.
42. Goldsmith A, Hershenson MB, Wolbert MP, Bentley JK. Regulation of airway smooth muscle α-actin expression by glucocorticoids. Am J Physiol Lung Cell Mol Physiol 2006; 292: L99-L106.
43. McMillan SJ, Xanthou G, Lloyd CM. Therapeutic administration of budesonide ameliorates allergen-induced airway remodelling. Clin Exp Allergy 2005; 35: 388-396.
44. Rogers DF, Barnes PJ. Treatment of airway mucus hypersecretion. Ann Med 2006; 38: 116-125.
45. Kai H, Yoshitake K, Hisatsune A, et al. Dexamethasone suppresses mucus production and MUC-2 and MUC-5AC gene expression by NCI-H292 cells. Am J Physiol 1996; 271: L484-L488.